Empaa-L (25/5mg) 14 Tablets

Linagliptin and Empagliflozin work together to lower blood sugar levels in individuals with type 2 diabetes. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor; it blocks the breakdown of incretin hormones, such as GLP-1 (glucagon-like peptide-1), which stimulate insulin secretion and reduce glucagon secretion in a glucose-dependent manner. This leads to increased insulin production and decreased glucagon release, resulting in better blood sugar control. Empagliflozin, on the other hand, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It works by blocking the reabsorption of glucose in the kidneys, promoting the elimination of glucose through urine, and lowering blood sugar levels. By combining these two mechanisms, Linagliptin and Empagliflozin provide a synergistic effect in managing blood glucose levels.

Linagliptin 5mg, Empagliflozin 25mg

DPP-4 inhibitor and SGLT2 inhibitor.

Tablet

The following are the uses of Linagliptin 5mg, Empagliflozin 25mg Tablet:

• Used for managing type 2 diabetes by controlling blood sugar levels.
• Used to reduce the risk of cardiovascular events in diabetic patients.
• Used to lower blood sugar levels by inhibiting the enzyme DPP-4.
• Used to increase glucose excretion in the urine by inhibiting SGLT2.
• Used to improve glycemic control when diet and exercise alone aren't sufficient.
• Used to promote weight loss and lower blood pressure as additional benefits.
• Used to potentially reduce the risk of diabetic kidney disease progression.
• Used as part of a comprehensive diabetes management plan.

Tailoring Treatment for Optimal Health, Prescribed Medication Dosage is:

• For treatment of diabetes mellitus, the recommended starting dose of Empagliflozin is 12.5 mg once daily. The maximum recommended dose is 25 mg once daily.
• For Linagliptin, the starting dose is 5 mg once daily, and the maximum dose is 5 mg once daily.

In the case of an overdose of Linagliptin 5mg and Empagliflozin 25mg tablets, the primary concern is the potential for severe hypoglycemia, especially in individuals with type 2 diabetes. Symptoms may include excessive sweating, tremors, and rapid heartbeat. Prompt medical attention is necessary, as healthcare professionals can provide guidance on managing the overdose, which may involve monitoring blood glucose levels and administering appropriate treatment to stabilize the patient's condition.

In the case of a missed dose of Linagliptin 5mg, it is recommended to take the medication as soon as you remember, but if it's close to the time for your next dose, skip the missed dose and continue with your regular schedule. For Empagliflozin 25mg, if you miss a dose, take it as soon as you remember, but avoid taking it if it's almost time for your next dose. Do not double the dose to make up for a missed one. Consult your healthcare provider if you frequently miss doses to ensure proper management of your medication regimen.

To take the Linagliptin 5mg and Empagliflozin 25mg Tablet, swallow one tablet with a glass of water, preferably at the same time each day, as directed by your healthcare provider, and it can be taken with or without food.

Following are the conditions or situations when Linagliptin 5mg, Empagliflozin 25mg Tablet should not be taken:

• Should not be used in patients with a known allergy to Linagliptin, Empagliflozin, or any of its components.
• Contraindicated in patients with severe kidney disease or end-stage renal disease.
• Not recommended for individuals with type 1 diabetes or diabetic ketoacidosis.
• Should not be used in patients with a history of a serious allergic reaction to any DPP-4 inhibitor.
• Contraindicated in patients with a history of a severe allergic reaction to Linagliptin or Empagliflozin.
• Not suitable for individuals with a history of pancreatitis.
• Should not be used in patients with moderate to severe liver disease.
• Not recommended during pregnancy or breastfeeding.
• Should be discontinued if a patient experiences a significant drop in blood sugar levels (hypoglycemia).

The side effects of Linagliptin 5mg, Empagliflozin 25mg Tablet may include:

• Stomach pain or upset
• Nausea and vomiting
• Diarrhea
• Headache
• Upper respiratory tract infection
• Dizziness
• Genital yeast infections
• Increased urination

Following are the precautions and warnings for Linagliptin 5mg, Empagliflozin 25mg Tablet:

• Patients with a known hypersensitivity or allergy to Linagliptin, Empagliflozin, or any of the tablet's components should not take this medication.
• This medication may affect kidney function; regular monitoring is necessary, especially for those with pre-existing kidney issues.
• Caution is advised for patients with type 1 diabetes, diabetic ketoacidosis, or a history of pancreatitis.
• It may cause fluid loss and volume depletion, so patients should be monitored for signs of dehydration, especially in hot environments or during heavy exercise.
• Linagliptin, Empagliflozin Tablet may increase the risk of genital and urinary tract infections; patients should be educated about the symptoms and seek medical advice if they occur.
• Patients with a history of liver disease should exercise caution, as this medication can affect liver function.
• This medication is not recommended for use in pregnant or breastfeeding women unless the potential benefits outweigh the risks.
• Elderly patients may be more susceptible to the effects and side effects of this medication, so dosage adjustments might be required.

Following are the drug interactions for Linagliptin 5mg, Empagliflozin 25mg Tablet:

• Concomitant use with insulin or insulin secretagogues (e.g., sulfonylureas) may increase the risk of hypoglycemia. Close monitoring of blood glucose is recommended.
• Linagliptin may reduce the metabolism of certain drugs metabolized by CYP3A4, such as some statins and calcium channel blockers, leading to increased levels of these medications.
• Empagliflozin can cause volume depletion, so caution is advised when used with diuretics or other drugs that may reduce intravascular volume.
• The diuretic effects of Empagliflozin may reduce the efficacy of antihypertensive medications. Blood pressure monitoring is necessary.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) may decrease the diuretic and blood pressure-lowering effects of Empagliflozin.
• Empagliflozin may increase the risk of genital yeast infections, and concurrent use with immunosuppressants may further enhance this risk.
• Drugs that affect kidney function, such as ACE inhibitors or ARBs, may require dose adjustments when used with Empagliflozin.
• Empagliflozin may increase the risk of dehydration, so caution is needed when used with other medications that can cause dehydration or electrolyte imbalances.

Following are the food interactions for Linagliptin 5mg, Empagliflozin 25mg Tablet:

• Grapefruit and grapefruit juice should be consumed with caution as they may alter the drug's metabolism, potentially affecting blood sugar control.
• Alcohol intake should be monitored as it can affect blood sugar levels, and combined with the medication, may increase the risk of hypoglycemia or other side effects.
• High-fat meals may slightly increase the absorption of Linagliptin, but this effect is not clinically significant.
• There is no specific food interaction with Empagliflozin, but maintaining a balanced diet is essential for overall diabetes management.
• Avoid excessive consumption of sugary foods and beverages as they can impact blood sugar levels.
• Consuming a consistent amount of carbohydrates at regular intervals is recommended to maintain stable blood sugar levels.
• Staying hydrated is important, especially with Empagliflozin, as it can increase urination.
• No significant food interactions have been reported, but it's best to consult your healthcare provider for personalized advice.

Linagliptin 5mg and Empagliflozin 25mg tablets should be stored in a cool, dry place, preferably at room temperature between 68°F and 77°F (20°C and 25°C). Protect the tablets from excessive heat, moisture, and direct sunlight by keeping them in their original packaging or container. Always check the expiration date and do not use the medication if it is expired. When disposing of unused or expired tablets, do not throw them into the trash or flush them down the toilet. Instead, utilize medication take-back programs or follow local guidelines for pharmaceutical waste disposal to ensure proper and safe disposal. Keep the medication in a secure location, out of the sight and reach of children and pets, to prevent accidental ingestion.

Following are the quick tips for Linagliptin 5mg and Empagliflozin 25mg Tablet:

• Consult your doctor for the right dosage and duration based on your medical condition.
• Take the tablet as directed, typically once daily with or without food.
• Swallow the tablet whole with a glass of water, do not crush or chew.
• Maintain a consistent medication schedule for better effectiveness.
• Do not stop taking the medication without consulting your doctor.
• Inform your doctor about all medications you are currently taking.
• Regularly monitor your blood sugar levels as advised by your healthcare provider.

When taking medications like Empagliflozin and Linagliptin, it is crucial to undergo specific lab tests to ensure your safety and adjust your dosage if required. Here is a paragraph format of the provided information: